A 57-year-old woman was admitted to our hospital for progressive hypoxic respiratory failure that developed after 10 days of empiric treatment at another hospital for an exacerbation of chronic obstructive pulmonary disease (COPD).
overall clinical status, these were thought to be trivial. Tests for immunoglobulin defi ciencies and human immunodefi ciency virus were negative, ruling out primary immunodefi ciency. However, within the next 48 hours, her respiratory status declined, and voriconazole was started out of concern for invasive pulmonary aspergillosis based on results of serum IgG testing.
Despite 2 days of treatment with voriconazole, the patient developed respiratory failure. Repeat CT showed that the ground-glass opacities were more dense, especially in the lower lobes, and new patchy infi ltrates were noted in the left lung. The patient developed a right tension pneumothorax requiring emergency intubation and chest tube insertion. 
DISSEMINATED ASPERGILLOSIS
She subsequently developed acute abdominal pain with worsening abdominal distention, diagnosed as pneumoperitoneum. Emergency exploratory laparotomy revealed perforations in the cecum with fecal spillage, requiring ileo cecectomy and ileostomy.
Pathologic study of bowel specimens confi rmed fungal hyphae with "tree-branch" structures consistent with fungal infection in the bowel (Figure 2) .
Oral voriconazole was continued. The patient's respiratory status improved, and she no longer required supplemental oxygen. She was discharged on a regimen of oral voriconazole 200 mg twice daily. However, over the next 12 months, she had additional hospitalizations for severe sepsis from abdominal wound infections, pneumonia, and Clostridium diffi cile infection. She will require lifelong antifungal treatment.
■ INVASIVE PULMONARY ASPERGILLOSIS
Invasive pulmonary aspergillosis is the most severe form of aspergillosis and is most often seen in immunocompromised patients. The death rate is as high as 50% in neutropenic patients regardless of the time to diagnosis or effective treatment. 2 It becomes life-threatening as the infection enters the blood stream, leading to formation of thrombi and precipitating embolism and necrosis in the lungs. 3 In immunocompetent patients, COPD, tuberculosis, bronchiectasis, liver disease, severe sepsis, and diabetes mellitus predispose to invasive pulmonary aspergillosis. 2 Other risk factors include long-term steroid therapy at doses equivalent to prednisone 20 mg/day for at least 13 weeks 4 and viral infection such as infl uenza. 5 Chronic use of inhaled corticosteroids has been hypothesized to increase risk.
